Prevalence of hyperaldosteronism in primary care patients with resistant hypertension

2012 | journal article; research paper

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Prevalence of hyperaldosteronism in primary care patients with resistant hypertension​
Schmiemann, G.; Gebhardt, K.; Hummers-Pradier, E.   & Egidi, G.​ (2012) 
Journal of the American Board of Family Medicine25(1) pp. 98​-103​.​ DOI: https://doi.org/10.3122/jabfm.2012.01.110099 

Documents & Media

License

GRO License GRO License

Details

Authors
Schmiemann, Guido; Gebhardt, Klaus; Hummers-Pradier, Eva ; Egidi, Günther
Abstract
Because hyperaldosteronism is the most common curable reason for secondary hypertension, screening is recommended. However, prevalence among general practice patients and feasibility of screening is still unclear. A design to assess prevalence in general practice and barriers against screening was created.
Issue Date
2012
Journal
Journal of the American Board of Family Medicine 
ISSN
1557-2625
eISSN
1558-7118
Language
English

Reference

Citations


Social Media